Bryce Point Capital »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Bryce Point Capital

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Bryce Point Capital from 13F filings

Historical chart of Bryce Point Capital investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Bryce Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Bryce Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $265k 6.8k 38.83

More positions owned by Bryce Point Capital

Freshpet (FRPT)
Wayfair Cl A (W)
Teleflex Incorporated (TFX)
Transmedics Group (TMDX)
Option Care Health Com New (OPCH)
Bright Horizons Fam Sol In D (BFAM)
Tecnoglass Ord Shs (TGLS)
Valvoline Inc Common (VVV)
Alight Com Cl A (ALIT)
Hayward Hldgs (HAYW)
Scotts Miracle-gro Cl A (SMG)
Carvana Cl A (CVNA)
Globalstar Com New (GSAT)
Chemours (CC)
Casella Waste Sys Cl A (CWST)

View all positions for Bryce Point Capital

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A